| scholarly article | Q13442814 |
| P2093 | author name string | M C Shuhart | |
| D R Gretch | |||
| A G Singal | |||
| L V Thomassen | |||
| P2860 | cites work | Quantification of Hepatitis C Virus (HCV) in Liver Specimens and Sera from Patients with Human Immunodeficiency Virus Coinfection by Using the Versant HCV RNA 3.0 (Branched DNA-Based) DNA Assay | Q27477673 |
| Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention | Q28286743 | ||
| Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach | Q29614698 | ||
| Diagnosis, management, and treatment of hepatitis C: an update | Q29619682 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Diagnosis, management, and treatment of hepatitis C | Q29620656 | ||
| HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease | Q33227070 | ||
| Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. | Q34326379 | ||
| The burden of hepatitis C in the United States | Q34984035 | ||
| Noninvasive monitoring of patients with chronic hepatitis C. | Q34984046 | ||
| Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection | Q35176164 | ||
| Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients | Q35595809 | ||
| Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes | Q35760270 | ||
| Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models | Q36729392 | ||
| Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review | Q36912964 | ||
| Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C. | Q37516476 | ||
| Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States | Q40249402 | ||
| Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group | Q43036483 | ||
| Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection | Q43807978 | ||
| Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model | Q44151781 | ||
| Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort | Q44381562 | ||
| A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. | Q44527614 | ||
| Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection | Q44920531 | ||
| Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival | Q45334756 | ||
| Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus | Q45383108 | ||
| Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients. | Q45422802 | ||
| Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients | Q45728692 | ||
| Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis | Q45736423 | ||
| Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study | Q45737816 | ||
| Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus | Q45739624 | ||
| Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups | Q45762654 | ||
| Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index | Q46490993 | ||
| Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. | Q46573661 | ||
| Chronic hepatitis. An update on terminology and reporting. | Q53635198 | ||
| Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies | Q70032258 | ||
| Outpatient liver biopsy: how safe is it? | Q70520158 | ||
| Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis | Q79972021 | ||
| Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: comparison of the APRI and FIB-4 index | Q81764068 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 566-577 | |
| P577 | publication date | 2011-01-05 | |
| P1433 | published in | Alimentary Pharmacology & Therapeutics | Q4726656 |
| P1476 | title | Use of the AST to platelet ratio index in HCV/HIV co-infected patients | |
| P478 | volume | 33 |
| Q35685126 | Accuracy of ultrasound and noninvasive markers of fibrosis to identify patients with cirrhosis |
| Q37199708 | Assessment of liver disease (noninvasive methods) |
| Q28080225 | Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C |
| Q35915477 | Direct and Indirect Serum Markers of Liver Fibrosis Compared with Transient Elastography among Women in the Women's Interagency HIV Study |
| Q37684651 | Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis |
| Q33576161 | Hepatitis C Virus Treatment in HIV-Coinfected Patients: No Longer Different From Monoinfection Treatment |
| Q26865956 | Non-invasive diagnosis of liver fibrosis in chronic hepatitis C |
| Q38074087 | Role of liver biopsy in the era of direct-acting antivirals. |
Search more.